MedPacto Correlations

235980 Stock  KRW 4,650  50.00  1.06%   
The current 90-days correlation between MedPacto and Green Cross Lab is 0.56 (i.e., Very weak diversification). The correlation of MedPacto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

MedPacto Correlation With Market

Average diversification

The correlation between MedPacto and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MedPacto and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to MedPacto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MedPacto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MedPacto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MedPacto to buy it.

Moving together with MedPacto Stock

  0.64207940 Samsung BiologicsPairCorr
  0.65302440 SK BiosciencePairCorr
  0.82144510 Green Cross LabPairCorr
  0.62334970 Prestige BiologicsPairCorr
  0.87086890 ISU AbxisPairCorr
  0.84005930 Samsung ElectronicsPairCorr
  0.84005935 Samsung ElectronicsPairCorr
  0.88005490 POSCO HoldingsPairCorr
  0.8034730 SK HoldingsPairCorr
  0.85034220 LG DisplayPairCorr

Moving against MedPacto Stock

  0.57030200 KT CorporationPairCorr
  0.36011200 HMM CoPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between MedPacto Stock performing well and MedPacto Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MedPacto's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in MedPacto without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module